Biotechnology

GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive dialogue after scientific review can effectively build trust and transparency

Indegene stock rose around 3.5 per cent to hit an intraday high of ₹568.2 on the NSE as ICICI Securities has initiated coverage with 'Add' rating

NITI Aayog suggests developing herbicide-tolerant pulses varieties and including pulses in welfare programs like PDS to boost domestic production and ensure self-sufficiency in pulses production

Shares of Anthem Biosciences surged 9 per cent to ₹820 on the BSE in Thursday's intra-day trade amid heavy volumes after reporting a strong earnings for the quarter ended June 2025.

Driven by state strategy, rapid innovation, and industrial dominance, China's surge in EVs, renewables, and biotech is not just disrupting industries, it's rewriting the global technological order

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough designations as they gain confidence in China's biotech innovation

The South Island giant moa may be Colossal Biosciences' next de-extinction project - but scientists caution the outcome won't truly be a moa

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets

To commercialise transcatheter aortic valve system in India, Europe and other select markets

This initiative reinforces the company's mission to provide deep life sciences-backed, innovative shrimp and fish health and farm care solutions

The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development

Genome sequencing, a laboratory technique used to decode the entire genetic composition of an organism or cell type, lies at the heart of the project

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India Data, that represents the genetic diversity in the country, will be available to researchers at the Indian Biological Data Centre (IBDC) through managed access. "I am confident this will be a milestone in the field of biotechnology research," Modi said in a video-recorded statement played out at the Genomics Data Conclave organised by the Department of Biotechnology here. Modi said more than 20 renowned research institutions like IITs, Council of Scientific and Industrial Research (CSIR), and Biotechnology Research and Innovation Centre (BRIC) have played an important role in this research. The prime minister said this national database encapsulated the extraordinary genetic landscape of the country and promised to serve as an invaluable scientific resource. "It will facilitate advancements

India's pharmaceutical sector is targeting $130 billion by 2030 and biotechnology is aiming for $300 billion by the same year: Great Place To Work report

Chinese biomedical research is on the cusp of a breakthrough just as the industry starts to face serious headwinds

Startup founded in 2016 say it will use the investment for crop protection research, products

Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation and foster culture of intellectual property. She highlighted how the country, already the world's largest exporter of generics and a major player in vaccine production, can achieve greater value by nurturing innovation. Mazumdar-Shaw called for a shift in focus toward value creation through innovation. "India ranks 14th in terms of value in the global pharma landscape. We need to invest in R&D and foster a culture of intellectual property to capture greater value," she said. Addressing a session during the Global Bio-India 2024 event, she positioned the country as a future global leader in biosciences and innovation. Mazumdar-Shaw emphasized India's unique advantages in becoming a global bio-innovation hub, citing the nation's rich scientific talent, robust technological capabilities, and entrepreneurial drive. "Biology is not only the most exciting and ...

The Biosecure Act would restrict federally funded medical providers from contracting with a select group of Chinese biotech companies

The Union Cabinet on Saturday approved the 'BioE3' (Biotechnology for Economy, Environment and Employment) policy for fostering high-performance biomanufacturing of the Department of Biotechnology. According to Information and Broadcasting Minister Ashwini Vaishnaw, the BioE3 policy seeks to include innovation-driven support for research and development and entrepreneurship across thematic sectors. This will accelerate technology development and commercialisation by establishing biomanufacturing and bio-AI hubs and biofoundry, he said. Along with prioritising regenerative bioeconomy models of green growth, this policy will facilitate the expansion of India's skilled workforce and provide a surge in job creation. An official statement said, the policy will further strengthen the government's initiatives such as a Net Zero' carbon economy and Lifestyle for Environment' and will steer India on the path of accelerated Green Growth' by promoting a Circular Bioeconomy'. "The BioE3 Polic

Zydus Lifesciences on Saturday said it has inked a pact with Perfect Day Inc to acquire 50 per cent stake in Sterling Biotech. As part of the deal, Perfect Day Inc, a Temasek portfolio company, will sell its 50 per cent shareholding in Sterling Biotech for an undisclosed amount. Post the transaction, Sterling Biotech will become a 50:50 joint venture with equal representation on the Board, Zydus Lifesciences said in a statement. Financial details of the deal were not shared. The JV will establish a manufacturing facility to manufacture fermented animal-free protein to cater to the global markets, it added. The acquisition also marks Zydus' foray into specialised biotech products for health and nutrition, specifically catering to consumers who prefer animal-free protein or suffer from lactose intolerance, the Gujarat-based firm said. Perfect Day's precision-fermented protein is found in ice creams, cream cheese, sports nutrition products, and baked goods with high functionality ..